KEY FEATURES
| Full Name | Insulin Like Growth Factor Binding Protein 7 |
|---|---|
| Synonym | AGM,FSTL2,IBP-7,IGFBP-7,IGFBP-7v,IGFBPRP1,MAC25,PSF,RAMSVPS,TAF, |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.16-10ng/mL |
| Sensitivity | 0.06ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human IGFBP-7 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human IGFBP-7. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human IGFBP-7 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human IGFBP-7, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human IGFBP-7. You can calculate the concentration of Human IGFBP-7 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human IGFBP-7 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 0.5 | 1.4 | 4.84 | 0.52 | 1.51 | 4.59 |
| Standard deviation | 0.03 | 0.08 | 0.22 | 0.04 | 0.09 | 0.18 |
| CV(%) | 5.96 | 5.91 | 4.62 | 6.96 | 5.96 | 3.98 |
RECOVERY
The recovery of Human IGFBP-7 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 91-107 | 98 |
| EDTA plasma (n=8) | 92-108 | 99 |
| Cell culture media (n=8) | 86-98 | 92 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human IGFBP-7 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with IGFBP7 ELISA Kits
| IGF2 ELISA Kit | publications with IGFBP7 and IGF2 |
| IGF1 ELISA Kit | publications with IGFBP7 and IGF1 |
| VEGFA ELISA Kit | publications with IGFBP7 and VEGFA |
| LIF ELISA Kit | publications with IGFBP7 and LIF |
| TP53 ELISA Kit | publications with IGFBP7 and TP53 |
Pathways associated with IGFBP7 ELISA Kit
| Cellular Senescence Pathway | Cellular Senescence Pathway |
| Cellular Responses To Stress Pathway | Cellular Responses To Stress Pathway |
| Senescence And Autophagy Pathway | Senescence And Autophagy Pathway |
| Senescence-Associated Secretory Phenotype (SASP) Pathway | Senescence-Associated Secretory Phenotype (SASP) Pathway |
Diseases associated with IGFBP7 ELISA Kit
| Carcinoma | publications with IGFBP7 and Carcinoma |
| Adenocarcinoma | publications with IGFBP7 and Adenocarcinoma |
| Leukemia | publications with IGFBP7 and Leukemia |
| Breast Neoplasms | publications with IGFBP7 and Breast Neoplasms |
| Neoplasms, Experimental | publications with IGFBP7 and Neoplasms, Experimental |
| Cardiovascular Diseases | publications with IGFBP7 and Cardiovascular Diseases |
| Liver Diseases | publications with IGFBP7 and Liver Diseases |
| Carcinoma, Squamous Cell | publications with IGFBP7 and Carcinoma, Squamous Cell |
| Liver Neoplasms | publications with IGFBP7 and Liver Neoplasms |
| Lung Neoplasms | publications with IGFBP7 and Lung Neoplasms |
Organs/Tissues associated with IGFBP7 ELISA Kit
| Blood | publications with IGFBP7 and Blood |
| Vascular | publications with IGFBP7 and Vascular |
| Brain | publications with IGFBP7 and Brain |
| Skin | publications with IGFBP7 and Skin |
| Embryonic Tissue | publications with IGFBP7 and Embryonic Tissue |
| Kidney | publications with IGFBP7 and Kidney |
| Lung | publications with IGFBP7 and Lung |
| Muscle | publications with IGFBP7 and Muscle |
| Liver | publications with IGFBP7 and Liver |
| Heart | publications with IGFBP7 and Heart |